Peregrine Pharma (NASDAQ: PPHM) announced the first of four presentations of clinical and preclinical data related to the company's immuno-oncology ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE